Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · G>A here scores Δ0.84 · evaluated, not missing |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 1.1 | GERP -1.3, phastCons 1 |
| Overall | ||
| CADD | 7.102 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 34.8% | 3 |
| Amishnot grpmax-eligible | 31.3% | 3 |
| European (non-Finnish)grpmax | 28.4% | 4 |
| Middle Eastern | 27.4% | 4 |
| Remaining individualsnot grpmax-eligible | 26.4% | 4 |
| Finnishnot grpmax-eligible | 25.3% | 4 |
| South Asian | 19.9% | 5 |
| Admixed American | 17.2% | 6 |
| African / African-American | 16.5% | 6 |
| East Asian | 16% | 6 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- HMBS
- Protein
- p.Val202=
- Coding
- c.606G>T
- MANE Select
- NM_000190
- dbSNP
- rs1131488
- Type
- single nucleotide variant
- Location
- chr11:119091520 (GRCh38)
- Gene constraint
- LOEUF 0.546 · pLI 0.81 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 90.54 · 11 PDB
- Residue 202
- a UniProt-annotated variant site (in aip)
Disease context
acute intermittent porphyria — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Acute intermittent porphyria (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adolescent, Adult
- Prevalence
- <1 / 1 000 000 (Europe)
Similar variants
- HMBS p.Val202Leu Uncertain significance ★★ ⚠ same residue
- HMBS c.160+5G>C Pathogenic/Likely pathogenic ★★ same condition
- HMBS c.345-1G>A Pathogenic ★★ same condition
- HMBS c.613-1G>A Pathogenic ★★ same condition
- HMBS c.826-2A>T Pathogenic/Likely pathogenic ★★ same condition
- HMBS c.913-1G>A Pathogenic ★★ same condition
- HMBS p.Ala331Val Pathogenic/Likely pathogenic ★★ ⚠ same condition
- HMBS p.Arg116Trp Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/hmbs-p-val202 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown